id:"swepub:oai:gup.ub.gu.se/295883"
Search: id:"swepub:oai:gup.ub.gu.se/295883" > Serum Glial Fibrill...
- 1 of 1
- Previous record
- Next record
- To hitlist
Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration.
- Benussi, Alberto (author)
-
- Ashton, Nicholas J. (author)
- Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
-
- Karikari, Thomas (author)
- Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
- show more...
- Gazzina, Stefano (author)
- Premi, Enrico (author)
- Benussi, Luisa (author)
- Ghidoni, Roberta (author)
- Binetti, Giuliano (author)
- Fostinelli, Silvia (author)
- Giunta, Marcello (author)
- Gasparotti, Roberto (author)
- Borroni, Barbara (author)
- show less...
- (creator_code:org_t)
- 2020
- 2020
- English.
- In: Journal of Alzheimer's disease : JAD. - 1875-8908. ; 77:3, s. 1129-1141
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- It is still unknown if serum glial fibrillary acidic protein (GFAP) is a useful marker in frontotemporal lobar degeneration (FTLD).To assess the diagnostic and prognostic value of serum GFAP in a large cohort of patients with FTLD.In this retrospective study, performed on 406 participants, we measured serum GFAP concentration with an ultrasensitive Single molecule array (Simoa) method in patients with FTLD, Alzheimer's disease (AD), and in cognitively unimpaired elderly controls. We assessed the role of GFAP as marker of disease severity by analyzing the correlation with clinical variables, neurophysiological data, and cross-sectional brain imaging. Moreover, we evaluated the role of serum GFAP as a prognostic marker of disease survival.We observed significantly higher levels of serum GFAP in patients with FTLD syndromes, except progressive supranuclear palsy, compared with healthy controls, but not compared with AD patients. In FTLD, serum GFAP levels correlated with measures of cognitive dysfunction and disease severity, and were associated with indirect measures of GABAergic deficit. Serum GFAP concentration was not a significant predictor of survival.Serum GFAP is increased in FTLD, correlates with cognition and GABAergic deficits, and thus shows promise as a biomarker of disease severity in FTLD.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Neurosciences (hsv//eng)
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Journal of Alzheimer's disease : JAD (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Benussi, Alberto
- Ashton, Nicholas ...
- Karikari, Thomas
- Gazzina, Stefano
- Premi, Enrico
- Benussi, Luisa
- show more...
- Ghidoni, Roberta
- Lantero Rodrigue ...
- Emersic, Andreja
- Binetti, Giulian ...
- Fostinelli, Silv ...
- Giunta, Marcello
- Gasparotti, Robe ...
- Zetterberg, Henr ...
- Blennow, Kaj, 19 ...
- Borroni, Barbara
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Basic Medicine
- and Neurosciences
- Articles in the publication
- Journal of Alzhe ...
- By the university
- University of Gothenburg
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
